Skip to content

Siren, L.L.C.

Follow

13F filer, CIK 2005245, New York, NY

Siren, L.L.C. reported $4,941,404,255 across 117 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. Its ten largest share positions make up 44.77% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002005245-26-000008

Period
2026-06-30
Reported value
$4.94B
Holdings
117
Top 10 weight
44.77%
New
27
Sold out
10

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PBLSnew+2,992,259$81.9M
ABVXnew+576,000$76.8M
COAGnew+2,086,834$76.6M
RLAYnew+3,650,000$68.3M
ELVNadded+1,028,185$52.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SRRKreduced-1,250,000-$68.8M
EWTXreduced-1,245,634-$50.6M
CNTAexited-1,053,464-$41.8M
RVMDreduced-210,980-$39.5M
ENGNexited-5,253,159-$35.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0002005245-26-000008, largest first. % of portfolio is the value over $4,925,796,495, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 11,259,438 shares; 2024Q4: 9,250,005 shares; 2025Q1: 9,250,005 shares; 2025Q2: 9,250,005 shares; 2025Q3: 9,250,005 shares; 2025Q4: 10,825,013 shares; 2026Q1: 10,825,013 shares; 2026Q2: 9,575,013 shares 9,575,013$527M10.69%-1,250,000Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,969,733 shares; 2024Q4: 2,969,733 shares; 2025Q1: 3,240,313 shares; 2025Q2: 3,428,150 shares; 2025Q3: 3,428,150 shares; 2025Q4: 3,286,830 shares; 2026Q1: 3,186,830 shares; 2026Q2: 2,935,830 shares 2,935,830$337M6.83%-251,000Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 8,857,179 shares; 2024Q4: 8,857,179 shares; 2025Q1: 8,757,249 shares; 2025Q2: 8,757,249 shares; 2025Q3: 8,757,249 shares; 2025Q4: 8,757,249 shares; 2026Q1: 11,244,246 shares; 2026Q2: 11,397,781 shares 11,397,781$209M4.24%+153,535Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,505,374 shares; 2026Q2: 1,655,374 shares 1,655,374$204M4.13%+150,000Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,603,897 shares; 2024Q4: 2,603,897 shares; 2025Q1: 2,565,342 shares; 2025Q2: 3,364,814 shares; 2025Q3: 5,883,188 shares; 2025Q4: 8,165,374 shares; 2026Q1: 5,657,105 shares; 2026Q2: 6,179,364 shares 6,179,364$193M3.92%+522,259Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 753,601 shares; 2024Q4: 571,548 shares; 2025Q1: 563,755 shares; 2025Q2: 938,755 shares; 2025Q3: 1,043,720 shares; 2025Q4: 1,335,075 shares; 2026Q1: 1,110,980 shares; 2026Q2: 900,000 shares 900,000$169M3.42%-210,980Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,072,827 shares; 2024Q4: 3,272,827 shares; 2025Q1: 3,267,083 shares; 2025Q2: 5,216,969 shares; 2025Q3: 5,216,969 shares; 2025Q4: 5,216,969 shares; 2026Q1: 5,802,970 shares; 2026Q2: 5,602,970 shares 5,602,970$166M3.38%-200,000Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,458,778 shares; 2024Q4: 2,901,681 shares; 2025Q1: 2,669,880 shares; 2025Q2: 2,669,880 shares; 2025Q3: 2,669,880 shares; 2025Q4: 1,500,476 shares; 2026Q1: 1,615,476 shares; 2026Q2: 1,715,476 shares 1,715,476$140M2.84%+100,000Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 563,314 shares; 2024Q4: 653,721 shares; 2025Q1: 498,689 shares; 2025Q2: 509,990 shares; 2025Q3: 492,990 shares; 2025Q4: 500,000 shares; 2026Q1: 465,000 shares; 2026Q2: 465,000 shares 465,000$133M2.69%0Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 404,113 shares; 2024Q4: 734,343 shares; 2025Q1: 1,696,444 shares; 2025Q2: 3,160,298 shares; 2025Q3: 3,897,099 shares; 2025Q4: 4,529,990 shares; 2026Q1: 4,430,263 shares; 2026Q2: 3,184,629 shares 3,184,629$129M2.63%-1,245,634Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 277,533 shares; 2025Q2: 409,742 shares; 2025Q3: 499,975 shares; 2025Q4: 499,975 shares; 2026Q1: 725,511 shares; 2026Q2: 1,136,275 shares 1,136,275$126M2.56%+410,764Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 38,918,903 shares; 2024Q4: 38,918,903 shares; 2025Q1: 38,918,903 shares; 2025Q2: 38,918,903 shares; 2025Q3: 38,918,903 shares; 2025Q4: 38,918,903 shares; 2026Q1: 44,303,518 shares; 2026Q2: 44,303,518 shares 44,303,518$106M2.16%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 746,226 shares; 2026Q2: 1,774,411 shares 1,774,411$90.1M1.83%+1,028,185Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 374,000 shares; 2025Q1: 368,598 shares; 2025Q2: 368,598 shares; 2025Q3: 368,598 shares; 2025Q4: 818,598 shares; 2026Q1: 818,598 shares; 2026Q2: 968,598 shares 968,598$86M1.75%+150,000Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,992,259 shares 2,992,259$81.9M1.66%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 743,769 shares; 2024Q4: 743,769 shares; 2025Q1: 732,761 shares; 2025Q2: 812,761 shares; 2025Q3: 812,761 shares; 2025Q4: 812,761 shares; 2026Q1: 1,318,564 shares; 2026Q2: 1,318,564 shares 1,318,564$79.6M1.62%0Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,749,041 shares; 2024Q4: 3,749,041 shares; 2025Q1: 7,415,905 shares; 2025Q2: 7,415,905 shares; 2025Q3: 7,415,905 shares; 2025Q4: 7,690,405 shares; 2026Q1: 7,690,405 shares; 2026Q2: 7,690,405 shares 7,690,405$76.8M1.56%0Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 576,000 shares 576,000$76.8M1.56%newTimeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,086,834 shares 2,086,834$76.6M1.56%newTimeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,612,077 shares; 2024Q4: 1,612,077 shares; 2025Q1: 1,612,077 shares; 2025Q2: 1,612,077 shares; 2025Q3: 2,912,077 shares; 2025Q4: 3,007,077 shares; 2026Q1: 3,007,077 shares; 2026Q2: 2,420,430 shares 2,420,430$74.6M1.51%-586,647Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 854,379 shares; 2025Q3: 1,724,279 shares; 2025Q4: 1,629,279 shares; 2026Q1: 1,709,279 shares; 2026Q2: 1,859,279 shares 1,859,279$72M1.46%+150,000Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,650,000 shares 3,650,000$68.3M1.39%newTimeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,879,875 shares; 2024Q4: 6,602,475 shares; 2025Q1: 6,514,737 shares; 2025Q2: 11,014,737 shares; 2025Q3: 11,014,737 shares; 2025Q4: 10,129,913 shares; 2026Q1: 8,829,913 shares; 2026Q2: 9,846,579 shares 9,846,579$67.1M1.36%+1,016,666Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 919,493 shares; 2026Q2: 1,419,493 shares 1,419,493$66.8M1.36%+500,000Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,000,000 shares; 2025Q1: 2,247,347 shares; 2025Q2: 2,247,347 shares; 2025Q3: 2,247,347 shares; 2025Q4: 2,247,347 shares; 2026Q1: 1,995,347 shares; 2026Q2: 1,995,347 shares 1,995,347$65.3M1.33%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,071,865 shares; 2025Q2: 1,099,401 shares; 2025Q3: 913,401 shares; 2025Q4: 988,401 shares; 2026Q1: 988,401 shares; 2026Q2: 888,401 shares 888,401$65M1.32%-100,000Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 525,971 shares; 2024Q4: 402,323 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 613,952 shares; 2026Q2: 758,952 shares 758,952$64.7M1.31%+145,000Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,202,514 shares; 2025Q1: 2,202,514 shares; 2025Q2: 2,202,514 shares; 2025Q3: 2,202,514 shares; 2025Q4: 2,000,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 1,900,000 shares 1,900,000$63.6M1.29%-100,000Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,300,700 shares; 2026Q1: 4,756,949 shares; 2026Q2: 4,856,949 shares 4,856,949$60.8M1.23%+100,000Timeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,309,652 shares; 2024Q4: 1,609,652 shares; 2025Q1: 1,688,611 shares; 2025Q2: 1,688,611 shares; 2025Q3: 1,688,611 shares; 2025Q4: 1,507,636 shares; 2026Q1: 1,903,636 shares; 2026Q2: 1,420,788 shares 1,420,788$53.2M1.08%-482,848Timeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,214,286 shares 2,214,286$48.8M0.99%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,134,664 shares; 2024Q4: 1,347,456 shares; 2025Q1: 2,717,987 shares; 2025Q2: 4,836,437 shares; 2025Q3: 4,729,174 shares; 2025Q4: 3,502,941 shares; 2026Q1: 2,229,125 shares; 2026Q2: 2,129,125 shares 2,129,125$47.3M0.96%-100,000Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,026,811 shares; 2025Q4: 1,078,698 shares; 2026Q1: 1,328,698 shares; 2026Q2: 872,967 shares 872,967$46.9M0.95%-455,731Timeline
TBLATABOOLA.COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,969,495 shares; 2024Q4: 9,969,495 shares; 2025Q1: 9,969,495 shares; 2025Q2: 9,969,495 shares; 2025Q3: 9,969,495 shares; 2025Q4: 9,969,495 shares; 2026Q1: 9,969,495 shares; 2026Q2: 8,423,410 shares 8,423,410$42.1M0.86%-1,546,085Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 75,000 shares; 2026Q1: 257,485 shares; 2026Q2: 257,485 shares 257,485$39.3M0.8%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,831,770 shares; 2024Q4: 2,831,770 shares; 2025Q1: 2,789,833 shares; 2025Q2: 2,911,438 shares; 2025Q3: 2,911,438 shares; 2025Q4: 2,911,438 shares; 2026Q1: 2,911,438 shares; 2026Q2: 3,311,438 shares 3,311,438$36.4M0.74%+400,000Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 834,028 shares; 2024Q4: 834,028 shares; 2025Q1: 821,513 shares; 2025Q2: 821,513 shares; 2025Q3: 821,513 shares; 2025Q4: 1,396,513 shares; 2026Q1: 1,396,513 shares; 2026Q2: 1,396,513 shares 1,396,513$35.9M0.73%0Timeline
RELYREMITLY GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 25,000 shares; 2024Q4: 490,449 shares; 2025Q1: 490,449 shares; 2025Q2: 515,449 shares; 2025Q3: 1,618,271 shares; 2025Q4: 1,618,271 shares; 2026Q1: 1,543,271 shares; 2026Q2: 1,543,271 shares 1,543,271$34.6M0.7%0Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,211,357 shares; 2024Q4: 1,211,357 shares; 2025Q1: 1,193,410 shares; 2025Q2: 1,193,410 shares; 2025Q3: 1,193,410 shares; 2025Q4: 1,193,410 shares; 2026Q1: 1,193,410 shares; 2026Q2: 1,893,410 shares 1,893,410$34.5M0.7%+700,000Timeline
COFCAPITAL ONE FINL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 171,615 shares 171,615$34.4M0.7%newTimeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,906,060 shares; 2025Q1: 2,863,793 shares; 2025Q2: 3,938,793 shares; 2025Q3: 2,536,867 shares; 2025Q4: 2,286,867 shares; 2026Q1: 1,786,867 shares; 2026Q2: 1,786,867 shares 1,786,867$33.3M0.68%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,007,575 shares; 2024Q4: 1,007,575 shares; 2025Q1: 1,007,575 shares; 2025Q2: 1,007,575 shares; 2025Q3: 1,007,575 shares; 2025Q4: 1,007,575 shares; 2026Q1: 2,998,192 shares; 2026Q2: 2,998,192 shares 2,998,192$32.5M0.66%0Timeline
GOOGLALPHABET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 11,000 shares; 2024Q4: 7,000 shares; 2025Q1: 50,703 shares; 2025Q2: 50,703 shares; 2025Q3: 21,203 shares; 2025Q4: 20,703 shares; 2026Q1: 65,703 shares; 2026Q2: 90,000 shares 90,000$32.2M0.65%+24,297Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,857,362 shares; 2026Q1: 1,857,362 shares; 2026Q2: 1,857,362 shares 1,857,362$30.5M0.62%0Timeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,800,000 shares; 2026Q2: 2,474,764 shares 2,474,764$28.7M0.58%+674,764Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 325,000 shares; 2025Q2: 325,000 shares; 2025Q3: 325,000 shares; 2025Q4: 300,000 shares; 2026Q1: 300,000 shares; 2026Q2: 610,515 shares 610,515$26.9M0.55%+310,515Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 384,197 shares; 2024Q4: 384,197 shares; 2025Q1: 378,469 shares; 2025Q2: 378,469 shares; 2025Q3: 1,053,469 shares; 2025Q4: 708,469 shares; 2026Q1: 641,469 shares; 2026Q2: 641,469 shares 641,469$26.7M0.54%0Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,230,000 shares; 2026Q2: 1,480,586 shares 1,480,586$26.6M0.54%+250,586Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,958,646 shares; 2026Q2: 4,458,646 shares 4,458,646$25.5M0.52%+500,000Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 212,298 shares; 2026Q1: 270,118 shares; 2026Q2: 270,118 shares 270,118$25M0.51%0Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 250,000 shares 250,000$23.8M0.48%newTimeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,095,316 shares 1,095,316$23.8M0.48%newTimeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 900,000 shares; 2026Q2: 900,000 shares 900,000$23.4M0.48%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 725,000 shares 725,000$23.2M0.47%newTimeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,300,000 shares; 2026Q1: 3,734,866 shares; 2026Q2: 3,734,866 shares 3,734,866$22M0.45%0Timeline
TSMTAIWAN SEMICONDUCTOR MANUFACQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 25,000 shares; 2024Q4: 15,000 shares; 2025Q1: 28,500 shares; 2025Q2: 30,500 shares; 2025Q3: 28,200 shares; 2025Q4: 27,700 shares; 2026Q1: 42,200 shares; 2026Q2: 44,700 shares 44,700$21.3M0.43%+2,500Timeline
NVDANVIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 48,932 shares; 2024Q4: 48,932 shares; 2025Q1: 44,432 shares; 2025Q2: 49,985 shares; 2025Q3: 37,485 shares; 2025Q4: 37,485 shares; 2026Q1: 89,085 shares; 2026Q2: 95,000 shares 95,000$19M0.39%+5,915Timeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,870,000 shares; 2025Q4: not reported; 2026Q1: 3,328,287 shares; 2026Q2: 3,328,287 shares 3,328,287$17.3M0.35%0Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 450,000 shares; 2026Q1: 450,000 shares; 2026Q2: 450,000 shares 450,000$16.1M0.33%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,606,571 shares; 2024Q4: 4,396,100 shares; 2025Q1: 4,358,283 shares; 2025Q2: 4,358,283 shares; 2025Q3: 4,358,283 shares; 2025Q4: 6,288,783 shares; 2026Q1: 8,497,822 shares; 2026Q2: 8,497,822 shares 8,497,822$14.4M0.29%0Timeline
NBISNEBIUS GROUP N.V.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 120,000 shares; 2025Q1: 140,000 shares; 2025Q2: 51,000 shares; 2025Q3: 72,600 shares; 2025Q4: 76,218 shares; 2026Q1: 113,614 shares; 2026Q2: 52,000 shares 52,000$14.4M0.29%-61,614Timeline
MSFTMICROSOFT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 22,000 shares; 2024Q4: 23,000 shares; 2025Q1: 28,500 shares; 2025Q2: 16,150 shares; 2025Q3: 17,150 shares; 2025Q4: 15,000 shares; 2026Q1: 41,380 shares; 2026Q2: 37,500 shares 37,500$14M0.28%-3,880Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,457,711 shares; 2026Q2: 3,457,711 shares 3,457,711$13M0.26%0Timeline
GENBGENERATE BIOMEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 736,104 shares; 2026Q2: 736,104 shares 736,104$12.4M0.25%0Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,850,000 shares; 2026Q1: 5,850,000 shares; 2026Q2: 5,850,000 shares 5,850,000$11.9M0.24%0Timeline
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,666,666 shares 2,666,666$11.2M0.23%newTimeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,256,662 shares 6,256,662$10.8M0.22%newTimeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,082,000 shares; 2025Q2: 2,082,000 shares; 2025Q3: 2,082,000 shares; 2025Q4: 2,082,000 shares; 2026Q1: 2,082,000 shares; 2026Q2: 2,337,102 shares 2,337,102$10.7M0.22%+255,102Timeline
DDOGDATADOG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 32,925 shares; 2024Q4: 30,425 shares; 2025Q1: 47,425 shares; 2025Q2: 38,425 shares; 2025Q3: 32,925 shares; 2025Q4: 36,425 shares; 2026Q1: 54,300 shares; 2026Q2: 40,000 shares 40,000$10.4M0.21%-14,300Timeline
NOWSERVICENOW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,500 shares; 2024Q4: 5,605 shares; 2025Q1: 9,126 shares; 2025Q2: 5,126 shares; 2025Q3: 7,126 shares; 2025Q4: 35,630 shares; 2026Q1: 87,090 shares; 2026Q2: 100,000 shares 100,000$9.93M0.2%+12,910Timeline
AVGOBROADCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,000 shares; 2026Q1: 15,000 shares; 2026Q2: 25,000 shares 25,000$9.44M0.19%+10,000Timeline
IONQIONQ INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 500,000 shares; 2024Q4: 170,000 shares; 2025Q1: 170,000 shares; 2025Q2: 170,000 shares; 2025Q3: 170,000 shares; 2025Q4: 170,000 shares; 2026Q1: 170,000 shares; 2026Q2: 170,000 shares 170,000$9.05M0.18%0Timeline
FROGJFROG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 61,000 shares; 2024Q4: 120,116 shares; 2025Q1: 131,616 shares; 2025Q2: 107,116 shares; 2025Q3: 107,116 shares; 2025Q4: 93,616 shares; 2026Q1: 128,816 shares; 2026Q2: 95,500 shares 95,500$8.68M0.18%-33,316Timeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 625,000 shares 625,000$8.67M0.18%newTimeline
IRENIREN LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: 43,100 shares; 2026Q1: 43,100 shares; 2026Q2: 175,000 shares 175,000$8M0.16%+131,900Timeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 34,750 shares; 2024Q4: 36,500 shares; 2025Q1: 56,500 shares; 2025Q2: 56,500 shares; 2025Q3: 58,500 shares; 2025Q4: 51,500 shares; 2026Q1: 46,641 shares; 2026Q2: 32,500 shares 32,500$7.75M0.16%-14,141Timeline
CRWDCROWDSTRIKE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 25,000 shares; 2024Q4: 24,000 shares; 2025Q1: 25,000 shares; 2025Q2: 18,500 shares; 2025Q3: 18,500 shares; 2025Q4: 16,500 shares; 2026Q1: 23,070 shares; 2026Q2: 10,000 shares 10,000$7.63M0.15%-13,070Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 523,212 shares 523,212$7.57M0.15%newTimeline
PDDPDD HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 40,401 shares; 2024Q4: 52,901 shares; 2025Q1: 52,901 shares; 2025Q2: 52,901 shares; 2025Q3: 43,401 shares; 2025Q4: 63,401 shares; 2026Q1: 83,401 shares; 2026Q2: 95,000 shares 95,000$7.25M0.15%+11,599Timeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 892,074 shares; 2026Q2: 892,074 shares 892,074$6.94M0.14%0Timeline
DTDYNATRACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 82,729 shares; 2024Q4: 82,729 shares; 2025Q1: 87,729 shares; 2025Q2: 75,229 shares; 2025Q3: 100,229 shares; 2025Q4: 115,229 shares; 2026Q1: 150,000 shares; 2026Q2: 155,000 shares 155,000$6.81M0.14%+5,000Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 352,441 shares; 2025Q4: 427,141 shares; 2026Q1: 427,141 shares; 2026Q2: 427,141 shares 427,141$6.21M0.13%0Timeline
VTVTVTV THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 163,000 shares; 2025Q4: 163,000 shares; 2026Q1: 163,000 shares; 2026Q2: 163,000 shares 163,000$6.14M0.12%0Timeline
ELOXELOXX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares 400,000$5.55M0.11%newTimeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 411,250 shares; 2026Q2: 411,250 shares 411,250$5.34M0.11%0Timeline
BABAALIBABA GROUP HLDG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares 50,000$4.8M0.1%newTimeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 418,833 shares; 2024Q4: 418,833 shares; 2025Q1: 418,833 shares; 2025Q2: 418,833 shares; 2025Q3: 418,833 shares; 2025Q4: 347,718 shares; 2026Q1: 347,718 shares; 2026Q2: 347,718 shares 347,718$4.58M0.09%0Timeline
CLBTCELLEBRITE DI LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 60,000 shares; 2025Q3: 90,000 shares; 2025Q4: 150,000 shares; 2026Q1: 311,544 shares; 2026Q2: 311,544 shares 311,544$4.55M0.09%0Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,000,000 shares; 2026Q1: 4,000,000 shares; 2026Q2: 5,000,000 shares 5,000,000$4.36M0.09%+1,000,000Timeline
OUSTOUSTER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 67,500 shares 67,500$4.22M0.09%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,000,000 shares 2,000,000$4.18M0.08%newTimeline
AEVAAEVA TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 110,000 shares; 2026Q2: 145,459 shares 145,459$4.18M0.08%+35,459Timeline
SEERSEER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,000,000 shares; 2024Q4: 4,000,000 shares; 2025Q1: 4,000,000 shares; 2025Q2: 4,000,000 shares; 2025Q3: 4,000,000 shares; 2025Q4: 4,000,000 shares; 2026Q1: 2,458,673 shares; 2026Q2: 2,458,673 shares 2,458,673$4.08M0.08%0Timeline
NBPNOVABRIDGE BIOSCIENCESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,165,957 shares; 2025Q4: 3,000,000 shares; 2026Q1: 3,000,000 shares; 2026Q2: 2,004,739 shares 2,004,739$3.91M0.08%-995,261Timeline
GTLBGITLAB INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 35,000 shares; 2025Q3: 64,000 shares; 2025Q4: 99,000 shares; 2026Q1: 100,000 shares; 2026Q2: 125,000 shares 125,000$3.82M0.08%+25,000Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares 200,000$3.74M0.08%newTimeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 720,720 shares; 2024Q4: 720,720 shares; 2025Q1: 720,720 shares; 2025Q2: 720,720 shares; 2025Q3: 720,720 shares; 2025Q4: 720,720 shares; 2026Q1: 720,720 shares; 2026Q2: 720,720 shares 720,720$3.52M0.07%0Timeline
AGENAGENUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 775,000 shares; 2024Q4: not reported; 2025Q1: 500,000 shares; 2025Q2: 1,064,250 shares; 2025Q3: 1,064,250 shares; 2025Q4: 1,064,250 shares; 2026Q1: 1,064,250 shares; 2026Q2: 1,064,250 shares 1,064,250$3.26M0.07%0Timeline
MNDYMONDAY COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,000 shares; 2025Q4: 17,000 shares; 2026Q1: 25,000 shares; 2026Q2: 42,500 shares 42,500$3.08M0.06%+17,500Timeline
ZTSZOETIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 35,000 shares 35,000$2.52M0.05%newTimeline
WKWORKIVA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 10,000 shares; 2025Q1: 17,500 shares; 2025Q2: 28,000 shares; 2025Q3: 30,000 shares; 2025Q4: 79,123 shares; 2026Q1: 92,500 shares; 2026Q2: 45,000 shares 45,000$2.18M0.04%-47,500Timeline
NFLXNETFLIX INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 25,000 shares 25,000$1.78M0.04%newTimeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 282,586 shares; 2025Q2: 282,586 shares; 2025Q3: 318,264 shares; 2025Q4: 435,798 shares; 2026Q1: 435,798 shares; 2026Q2: 435,798 shares 435,798$1.77M0.04%0Timeline
QNTQUANTINUUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares 20,000$1.63M0.03%newTimeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,000,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 2,000,000 shares 2,000,000$1.52M0.03%0Timeline
TSLATESLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 9,000 shares; 2025Q2: 4,000 shares; 2025Q3: 1,500 shares; 2025Q4: 1,500 shares; 2026Q1: 21,500 shares; 2026Q2: 3,500 shares 3,500$1.47M0.03%-18,000Timeline
BEKEKE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 100,000 shares; 2024Q4: 60,000 shares; 2025Q1: 105,000 shares; 2025Q2: 105,000 shares; 2025Q3: 145,000 shares; 2025Q4: 145,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares 100,000$1.45M0.03%0Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 736,457 shares 736,457$1.3M0.03%newTimeline
MDLNMEDLINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 75,000 shares; 2026Q1: 25,000 shares; 2026Q2: 25,000 shares 25,000$986K0.02%0Timeline
LITELUMENTUM HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,055 shares 1,055$905K0.02%newTimeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 15,000 shares; 2025Q4: 25,000 shares; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares 50,000$904K0.02%0Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 13,281,610 shares; 2024Q4: 5,208,968 shares; 2025Q1: 5,208,968 shares; 2025Q2: 5,208,968 shares; 2025Q3: 5,208,968 shares; 2025Q4: 5,208,968 shares; 2026Q1: 5,208,968 shares; 2026Q2: 5,208,968 shares 5,208,968$857K0.02%0Timeline
FOXAFOX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,000 shares 10,000$522K0.01%newTimeline
TAT&T INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 25,000 shares 25,000$518K0.01%newTimeline
NUNU HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 50,000 shares; 2024Q4: 50,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 25,000 shares; 2026Q2: 25,000 shares 25,000$334K0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MSFTMICROSOFT CORP COMcall24,000$8.95Mnew
AAPLAPPLE INC COMcall23,000$6.66Mnew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CNTACENTESSA PHARMACEUTICALS PLC1,053,464$41.8Mshares
ENGNENGENE HOLDINGS INC5,253,159$35.8Mshares
FULCFULCRUM THERAPEUTICS INC2,350,000$18Mshares
WVEWAVE LIFE SCIENCES LTD2,450,000$17.8Mshares
QUREUNIQURE NV1,000,000$16.4Mshares
BCYCBICYCLE THERAPEUTICS PLC1,560,882$7.24Mshares
FPSFORGENT POWER SOLUTIONS INC100,000$2.93Mshares
MUMICRON TECHNOLOGY INC6,000$2.03Mshares
ASAMER SPORTS INC50,000$1.65Mshares
PRMBPRIMO BRANDS CORPORATION50,000$942Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002005245-26-000008 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0002005245-26-000008 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0002005245-26-000006 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0002005245-26-000003 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0002005245-25-000012 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0002005369-25-000014 Quarter ended 2025-06-302025-08-13acceptance time not in the bulk data set
13F-HR/A 0002005245-25-000008 Quarter ended 2025-03-312025-05-23acceptance time not in the bulk data set
13F-HR 0002005245-25-000006 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0002005245-25-000002 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0002005245-24-000005 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set